BioCentury | Sep 10, 2012
Company News

PGXL Laboratories, SureGene LLC sales and marketing update

...SureGene and partner PGXL launched the SureGene Test for Antipsychotic and Antidepressant Response (STA2R) in the...
...family 1 subfamily A polypeptide 2 (CYP1A2) to determine personalized antipsychotic and antidepressant drug selection. SureGene...
...its lab. SurGene and PGXL declined to disclose further details. PGXL Laboratories , Louisville, Ky. SureGene LLC...
BioCentury | Aug 30, 2010
Company News

Medco Health Solutions Inc., SureGene LLC deal

...manager Medco's Medco Research Institute LLC subsidiary partnered with SureGene to evaluate undisclosed biomarkers from SureGene...
...Ind.) markets Zyprexa olanzapine to treat schizophrenia. Medco Health Solutions Inc. (NYSE:MHS), Franklin Lakes, N.J. SureGene LLC...
Items per page:
1 - 2 of 2
BioCentury | Sep 10, 2012
Company News

PGXL Laboratories, SureGene LLC sales and marketing update

...SureGene and partner PGXL launched the SureGene Test for Antipsychotic and Antidepressant Response (STA2R) in the...
...family 1 subfamily A polypeptide 2 (CYP1A2) to determine personalized antipsychotic and antidepressant drug selection. SureGene...
...its lab. SurGene and PGXL declined to disclose further details. PGXL Laboratories , Louisville, Ky. SureGene LLC...
BioCentury | Aug 30, 2010
Company News

Medco Health Solutions Inc., SureGene LLC deal

...manager Medco's Medco Research Institute LLC subsidiary partnered with SureGene to evaluate undisclosed biomarkers from SureGene...
...Ind.) markets Zyprexa olanzapine to treat schizophrenia. Medco Health Solutions Inc. (NYSE:MHS), Franklin Lakes, N.J. SureGene LLC...
Items per page:
1 - 2 of 2